Cdk5 regulates Rap1 activity

被引:11
|
作者
Utreras, Elias [1 ]
Henriquez, Daniel [1 ]
Contreras-Vallejos, Erick [1 ]
Olmos, Cristina [1 ]
Di Genova, Alex [2 ,3 ]
Maass, Alejandro [2 ,3 ]
Kulkarni, Ashok B. [4 ]
Gonzalez-Billault, Christian [1 ]
机构
[1] Univ Chile, Lab Cellular & Neuronal Dynam, Dept Biol, Fac Sci, Santiago 7800024, Chile
[2] Univ Chile, Ctr Math Modeling, Santiago 7800024, Chile
[3] Univ Chile, Ctr Genome Regulat, Santiago 7800024, Chile
[4] NIDCR, Funct Genom Sect, NIH, Bethesda, MD USA
关键词
Signal transduction; Cyclin-dependent kinase 5; Rap1; C3G; Neurones; NUCLEOTIDE EXCHANGE FACTOR; NEURONAL POLARITY; UBIQUITIN LIGASE; FACTOR C3G; ACTIVATION; MIGRATION; PHOSPHORYLATION; EXPRESSION; GTPASES; CRK;
D O I
10.1016/j.neuint.2013.02.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rap1 signaling is important for migration, differentiation, axonal growth, and during neuronal polarity. Rap1 can be activated by external stimuli, which in turn regulates specific guanine nucleotide exchange factors such as C3G, among others. Cdk5 functions are also important to neuronal migration and differentiation. Since we found that pharmacological inhibition of Cdk5 by using roscovitine reduced Rap1 protein levels in COS-7 cells and also C3G contains three putative phosphorylation sites for Cdk5, we examined whether the Cdk5-dependent phosphorylation of C3G could affect Rap1 expression and activity. We co-transfected C3G and tet-OFF system for p35 over-expression, an activator of Cdk5 activity into COS-7 cells, and then we evaluated phosphorylation in serine residues in C3G by immunoprecipitation and Western blot. We found that p35 over-expression increased C3G-serine-phosphorylation while inhibition of p35 expression by tetracycline or inhibition of Cdk5 activity with roscovitine decreased it. Interestingly, we found that MG-132, a proteasome inhibitor, rescue Rap1 protein levels in the presence of roscovitine. Besides, C3G-serine-phosphorylation and Rap1 protein levels were reduced in brain from Cdk5(-/-) as compared with the Cdk5(+/+) brain. Finally, we found that p35 over-expression increased Rap1 activity while inhibition of p35 expression by tetracycline or roscovitine decreased Rap1 activity. These results suggest that Cdk5-mediated serine-phosphorylation of C3G may control Rap1 stability and activity, and this may potentially impact various neuronal functions such as migration, differentiation, and polarity. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:848 / 853
页数:6
相关论文
共 50 条
  • [31] A decade of CDK5
    Dhavan, R
    Tsai, LH
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) : 749 - 759
  • [32] Rap1 redux
    Abraham, RT
    NATURE IMMUNOLOGY, 2003, 4 (08) : 725 - 727
  • [33] Distinct functions of Cdk5(Y15) phosphorylation and Cdk5 activity in stress fiber formation and organization
    Qiao, Fengyu
    Gao, Chun Y.
    Tripathi, Brajendra K.
    Zelenka, Peggy S.
    EXPERIMENTAL CELL RESEARCH, 2008, 314 (19) : 3542 - 3550
  • [34] Rap1 redux
    Robert T Abraham
    Nature Immunology, 2003, 4 : 725 - 727
  • [35] Cdk5 on the brain
    Smith, DS
    Greer, PL
    Tsai, LH
    CELL GROWTH & DIFFERENTIATION, 2001, 12 (06): : 277 - 283
  • [36] Cdk5 at the junction
    Lee, MS
    Tsai, LH
    NATURE NEUROSCIENCE, 2001, 4 (04) : 340 - 342
  • [37] Ras and Rap1 activation of PLCε lipase activity
    Edamatsu, Hironori
    Satoh, Takaya
    Kataoka, Tohru
    REGULATORS AND EFFECTORS OF SMALL GTPASES: RAS FAMILY, 2006, 407 : 99 - 107
  • [38] Cyclin-dependent kinase 5 (CDK5) regulates the circadian clock
    Brenna, Andrea
    Olejniczak, Iwona
    Chavan, Rohit
    Ripperger, Jurgen A.
    Langmesser, Sonja
    Cameroni, Elisabetta
    Hu, Zehan
    De Virgilio, Claudio
    Dengjel, Jorn
    Albrecht, Urs
    ELIFE, 2019, 8
  • [39] Targeting Cdk5 Activity in Neuronal Degeneration and Regeneration
    Kanungo, Jyotshnabala
    Zheng, Ya-li
    Amin, Niranjana D.
    Pant, Harish C.
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2009, 29 (08) : 1073 - 1080
  • [40] Biological functions of CDK5 and potential CDK5 targeted clinical treatments
    Shupp, Alison
    Casimiro, Mathew C.
    Pestell, Richard G.
    ONCOTARGET, 2017, 8 (10) : 17373 - 17382